Pseudohypoparathyroidism type IA and II with severe neuropsychic manifestations

Turkish Journal of Pediatrics

Volumn 43, Issue 1, 2001, Pages 70-75

  Kutílek, Štěpán ^a   Kabíček, Pavel ^a   Nedvídková, Jara ^b   Bayer, Milan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Epilepsy; Hypocalcemia; Parathyroid hormone; Pseudohypoparathyroidism

Indexed keywords

PARATHYROID HORMONE;

ADOLESCENT; ANXIETY; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; GRAND MAL EPILEPSY; HUMAN; HYPOCALCEMIA; MALE; MENTAL DEFICIENCY; PARESTHESIA; PSEUDOHYPOPARATHYROIDISM; TETANY;

ADOLESCENT; ANXIETY; DIAGNOSIS, DIFFERENTIAL; EPILEPSY, TONIC-CLONIC; HUMANS; HYPOCALCEMIA; MALE; MENTAL RETARDATION; PARATHYROID HORMONE; PARESTHESIA; PSEUDOHYPOPARATHYROIDISM; TETANY;

EID: 0035236965     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. th ed). Vol. 2. Philadelphia: McGraw-Hill; 1995: 3073-3089.
2. Malette LE, Kirkland JL, Gagel RF, Law WM, Health H. Synthetic human parathyroid hormone (1-34) for the study of pseudohypoparathyroidism. J Clin Endocrinol Metab 1988; 67: 964-972.
3. Levine MA. Pseudohypoparathyroidism. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principles of Bone Biology. New York: Academic Press Inc; 1996: 853-876.
4. Walton RJ, Bijvoet OL. Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975; 2: 309-310.
5. Marguet C, Mallet E, Basuyau JP, Martin D, Leroy M, Brunelle P. Clinical and biological heterogeneity in pseudohypoparathyroidism syndrome. Horm Res 1997; 48: 120-130.
6. Pollard AJ, Prendergast M, al-Hammouri F, Rayner PH, Shaw NJ. Different subtypes of pseudohypoparathyroidism in the same family with an unusual psychiatric presentation of the index case. Arch Dis Child 1994; 70: 99-102.
7. Schuster V, Sandhage K. Intracardiac clacifications in a case of pseudohypoparathyroidism type Ia. Pediatr Cardiol 1992; 13: 237-239.
8. Schuster V, Eschenhagen T, Kruse K, Gierschik P, Kreth HW. Endocrine and molecular biological studies in a German family with Albright hereditary osteodystrophy. Eur J Pediatr 1993; 152: 185-189.
9. Tsang RC, Venkataraman P, Ho M, Steichen JJ, Whitsett J, Greer F. The development of pseudohypoparathyroidism. Involvement of progressively increasing serum parathyroid hormone concentrations, increased 1,25-dihydroxy vitamin D concentrations, and migratory subcutaneous calcifications. Am J Dis Child 1984; 138: 654.
10. Barr DG, Stirling HF, Darling JA. Evolution of pseudohypoparathyroidism: an informative family study. Arch Dis Child 1994; 70: 337-338.
11. Thakker RV. Molecular genetics of mineral metabolic disorders. J Inherit Metab Dis 1992; 15: 592-609.
12. de Wijn EM, Steendijk R. Growth and maturation in pseudohypoparathyroidism: a longitudinal study in five patients. Acta Endocrinol 1982; 101: 223-226.
13. Scott DC, Hung W. Pseudohypoparathyroidism type Ia and growth hormone deficiency in two siblings. J Pediatr Endocrinol Metabol 1995; 8: 205-207.
14. Levine MA. Pseudohyperparathyroidism: from bedside to bench and back. J Bone Miner Res 1999; 8: 1255-1260.
15. Bando Y, Miyakoshi H, Nagaoka T, Ohsawa K, Kobayashi K. A case of pseudohypoparathyroidism type II associated with Bartter's syndrome-restoration of phosphaturic response to parathyroid hormone by treatment for hypopotassemia. Nippon Naibunpi Gakkai Zasshi-Folia Endocrinologica Japonica 1992; 68: 676-687.
16. Rao DS, Parfitt AM, Kleerekoper M, Pumo BS, Frame B. Dissociation between the effects of endogenous parathyroid hormone on adenosine 3′, 5′-monophosphate generation and phosphate reabsorption in hypocalcaemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II. J Clin Endocrinol Metab 1985; 61: 285-290.
17. Rude RK. Magnesium deficiency in parathyroid function. In: Bilezikian JP (ed) The-Parathyroids. New York: Raven Press; 1994: 829-842.
18. Kruse K, Kracht U, Wohlfart K. Biochemical markers of bone turnover, intact serum parathyroid hormone and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment. Eur J Pediatr 1989; 148: 535-539.
19. Kruse K, Reiss I, Inderrieden D, Kutilek S, Acil Y, Agbenu J. Biochemical markers of bone turnover in . diseases of extracellular calcium and phosphate metabolism. In: Schonau E (ed). Paediatric Osteology: New Developments in Diagnostics and Therapy. Amsterdam: Elsevier Science; 1996: 203-220.